Male fetuses are particularly affected by maternal alloimmunization to D antigen

Transfusion

Volumn 39, Issue 2, 1999, Pages 169-173

  Ulm, Barbara ^a   Svolba, Gerhard ^b   Ulm, Martin R ^b   Bernaschek, Gerhard ^b   Panzer, Simon ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOIMMUNIZATION; ANEMIA; ARTICLE; FEMALE; FETOPLACENTAL UNIT; FETUS; FETUS HYDROPS; FETUS RISK; GESTATIONAL AGE; HEMATOCRIT; HIGH RISK POPULATION; HUMAN; INTRAUTERINE BLOOD TRANSFUSION; MAJOR CLINICAL STUDY; MALE; NEWBORN; PERINATAL MORTALITY; UMBILICAL CORD BLOOD;

EID: 0033049704     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1999.39299154731.x     Document Type: Article

References (18)

1. Schumacher B, Moise KJ Jr. Fetal transfusion for red blood cell alloimmunization in pregnancy. Obstet Gynecol 1996;88:137-50.
2. Woodrow JC, Donohoe WT. Rh-immunization by pregnancy: results of a survey and their relevance to prophylactic therapy. Br Med J 1968;4:139-44.
3. Woodrow JC. Maternal HL-A antibodies and fetal sex. Br Med J 1975;136.
4. Walker W, Mollison PL. Haemolytic disease of the newborn. Deaths in England and Wales during 1953 and 1955. Lancet 1957;1:1309-14.
5. Ulm B, Ulm MR, Panzer S. Fetal sex and hemolytic disease from maternal red-cell alloimmunization (letter). N Engl J Med 1998;338:1699-700.
6. Weiner CP, Williamson RA, Wenstrom KD, et al. Management of fetal hemolytic disease by cordocentesis. I. Prediction of fetal anemia. Am J Obstet Gynecol 1991;165:546-53.
7. Thomas MR, Tutschek B, Frost A, et al. The time of appearance and disappearance of fetal DNA from the maternal circulation. Prenat Diagn 1995;15:641-6.
8. Bonney EA, Matzinger P. The maternal immune system's interaction with circulating fetal cells. J Immunol 1997;158:40-7.
9. Pennisi E. Long-sought H-Y antigen found (news). Science 1995;269:1515-6.
10. Goulmy E, Termijtelen A, Bradley BA, van Rood JJ. Alloimmunity to human H-Y (letter). Lancet 1976;2:1206.
11. Goulmy E, Termijtelen A, Bradley BA, van Rood JJ. Y-antigen killing by T cells of women is restricted by HI.A. Nature 1977;266:544-5.
12. Voogt PJ, Fibbe WE, Marijt WA, et al. Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens. Lancet 1990;335:131-4.
13. Bortin MM. Acute graft-versus-host disease following bone marrow transplantation in humans: prognostic factors. Advisory Committee of the International Bone Marrow Transplant Registry. Transplant Proc 1987;19:2655-7.
14. De Bueger M, Bakker A, Van Rood JJ, et al. Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. J Immunol 1992;149:1788-94.
15. Wang W, Meadows LR, den Haan JM, et al. Human H-Y: a male-specific histocompatibility antigen derived from the SMCY protein. Science 1995;269:1588-90.
16. Scott DM, Ehrmann IE, Ellis PS, et al. Identification of a mouse male-specific transplantation antigen, H-Y. Nature 1995;376:695-8.
17. Von Boehmer H. Immunogenetics. Female anti-male attack (news). Nature 1995;376:642.
18. Dooren MC, Kuijpers RW, Joekes EC, et al. Protection against immune haemolytic disease of newborn infants by maternal monocyte-reactive IgG alloantibodies (anti-HLA-DR). Lancet 1992;339:1067-70.